Abstract
This study investigates the dose from the 1 mm collimator width megavoltage fan-beam CT (fine, normal and coarse pitch) available on tomotherapy as well as for whole-breast tomotherapy treatments. The BEIR VII lifetime attributable risk model was utilised to assess the significance of the imaging dose relative to the treatment dose.
Original language | English (US) |
---|---|
Pages (from-to) | 266-268 |
Number of pages | 3 |
Journal | Radiotherapy and Oncology |
Volume | 108 |
Issue number | 2 |
DOIs | |
State | Published - Aug 2013 |
Fingerprint
Keywords
- Breast
- Cancer risk
- CT
- Dose
- Megavoltage
- Tomotherapy
ASJC Scopus subject areas
- Oncology
- Radiology Nuclear Medicine and imaging
- Hematology
Cite this
Normal tissue dose and second cancer risk due to megavoltage fan-beam CT, static tomotherapy and helical tomotherapy in breast radiotherapy. / Quinn, Alexandra; Holloway, Lois; Hardcastle, Nicholas; Tome, Wolfgang A.; Rosenfeld, Anatoly; Metcalfe, Peter.
In: Radiotherapy and Oncology, Vol. 108, No. 2, 08.2013, p. 266-268.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Normal tissue dose and second cancer risk due to megavoltage fan-beam CT, static tomotherapy and helical tomotherapy in breast radiotherapy
AU - Quinn, Alexandra
AU - Holloway, Lois
AU - Hardcastle, Nicholas
AU - Tome, Wolfgang A.
AU - Rosenfeld, Anatoly
AU - Metcalfe, Peter
PY - 2013/8
Y1 - 2013/8
N2 - This study investigates the dose from the 1 mm collimator width megavoltage fan-beam CT (fine, normal and coarse pitch) available on tomotherapy as well as for whole-breast tomotherapy treatments. The BEIR VII lifetime attributable risk model was utilised to assess the significance of the imaging dose relative to the treatment dose.
AB - This study investigates the dose from the 1 mm collimator width megavoltage fan-beam CT (fine, normal and coarse pitch) available on tomotherapy as well as for whole-breast tomotherapy treatments. The BEIR VII lifetime attributable risk model was utilised to assess the significance of the imaging dose relative to the treatment dose.
KW - Breast
KW - Cancer risk
KW - CT
KW - Dose
KW - Megavoltage
KW - Tomotherapy
UR - http://www.scopus.com/inward/record.url?scp=84885387773&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84885387773&partnerID=8YFLogxK
U2 - 10.1016/j.radonc.2013.05.019
DO - 10.1016/j.radonc.2013.05.019
M3 - Article
C2 - 23849173
AN - SCOPUS:84885387773
VL - 108
SP - 266
EP - 268
JO - Radiotherapy and Oncology
JF - Radiotherapy and Oncology
SN - 0167-8140
IS - 2
ER -